The Opioid Use Disorder (OUD) Global Market Report 2023, provides comprehensive information on the opioid use disorder (OUD) market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Opioid Use Disorder (OUD) Market’s Growth:
As per The Business Research Company’s Opioid Use Disorder (OUD) Global Market Report 2023, the global opioid use disorder (OUD) market is expected to grow from $3.17 billion in 2022 to $3.53 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The opioid use disorder (OUD) market is expected to reach $5.37 billion in 2027 at a CAGR of 11%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
Product innovation is a key trend gaining popularity in the opioid use disorder (OUD) market. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.
The opioid use disorder (OUD) market is segmented:
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
North America was the largest region in the opioid use disorder (OUD) market in 2022.
The table of contents in TBRC’s opioid use disorder (OUD) market report includes:
- Executive Summary
- Opioid Use Disorder (OUD) Market Characteristics
- Opioid Use Disorder (OUD) Market Trends And Strategies
- Opioid Use Disorder (OUD) Market – Macro Economic Scenario
- Global Opioid Use Disorder (OUD) Market Size and Growth
- South America Opioid Use Disorder (OUD) Market
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Top 5 Major Key Player:
- Pfizer Inc
- Novartis AG
- AstraZeneca plc
- Viatris Inc
- Teva Pharmaceutical Industries Ltd
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model